Moleculin Announces 100% Survival Reached in Osteosarcoma Lung Metastases Animal Design
HOUSTON, Feb. 2, 2021 /PRNewswire/ — Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Firm),
HOUSTON, Feb. 2, 2021 /PRNewswire/ — Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Firm),